Moise Azria
26Patents
9h-index
33Co-inventors
75Inventor score
Filing activity: Dec 8, 1981 → May 21, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5561149A | Use of certain imidazol carbazols in treating stress-related manic-depressive disorders | Chemistry; Metallurgy | 90 | Expired |
| US7049283B2 | Pharmaceutical compositions for the oral delivery of pharmacologically active agents | Human Necessities | 31 | Expired |
| US4462983A | Certain ergot peptide alkaloids administered to the nasal mucosa | Physics | 26 | Expired |
| US5260321A | Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins | Emerging Cross-Sectional Technologies | 25 | Expired |
| US5759565A | Galenic compositions comprising calcitonin and their use | Human Necessities | 21 | Expired |
| US5733569A | Galenic compositions comprising calcitonin and their use | Human Necessities | 15 | Expired |
| US5149537A | Use of taurocholic acid and its salts as enhancers for calcitonin containing pharmaceutical compositions | Human Necessities | 11 | Expired |
| US4988512A | Nasal pharmaceutical compositions | Human Necessities | 11 | Expired |
| US5122520A | Acid addition salts of amidated taurine or glycine, their preparation and use | Chemistry; Metallurgy | 9 | Expired |
| US7659311B2 | Disodium salts, monohydrates, and ethanol solvates for delivering active agents | Human Necessities | 6 | Active |
| US8153587B2 | Orally administering parathyroid hormone and calcitonin | Human Necessities | 5 | Active |
| US7749954B2 | Use of calcitonin in osteoarthritis | Human Necessities | 4 | Expired |
| US7569539B2 | Oral administration of calcitonin | Human Necessities | 3 | Active |
| US8765675B2 | Use of calcitonin in osteoarthritis | Human Necessities | 2 | Active |
| US8658695B2 | Disodium salts, monohydrates, and ethanol solvates for delivering active agents | Human Necessities | 1 | Active |
| US4758423A | Certain ergot peptide alkaloids administered to the nasal mucosa | Physics | 1 | Expired |
| US8748383B2 | Method for treating bone related diseases and calcium disorders | Human Necessities | 1 | Active |
| US8207227B2 | Disodium salts, monohydrates, and ethanol solvates for delivering active agents | Human Necessities | 1 | Active |
| US8435946B2 | Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form | Human Necessities | 1 | Active |
| US8003697B2 | Disodium salts, monohydrates, and ethanol solvates for delivering active agents | Human Necessities | 1 | Active |
| US8664211B2 | Modified amino acid for the inhibition of platelet aggregation | Human Necessities | 0 | Active |
| US8835389B2 | Use of calcitonin for the treatment of RA | Human Necessities | 0 | Active |
| US7915314B2 | Disodium salts, monohydrates, and ethanol solvates for delivering active agents | General | 0 | Revoked |
| US8323688B2 | Pharmaceutical compositions comprising hGH for oral delivery | Human Necessities | 0 | Active |
| US9272040B2 | 5-CNAC as oral delivery agent for parathyroid hormone fragments | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.